Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda.
作者信息
Kwesiga Brendan, Wagner Anita Katharina, Seru Morries, Ross-Degnan Dennis, Trap Birna
机构信息
USAID/Uganda Health Supply Chain Program, Management Sciences for Health, Plot 15, Princess Anne Drive, Bugolobi, P.O. Box 71419, Kampala, Uganda.
Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive Suite 401, Boston, MA 02215 USA.
出版信息
J Pharm Policy Pract. 2019 Dec 3;12:36. doi: 10.1186/s40545-019-0196-8. eCollection 2019.
Abstract
摘要
相似文献
1
Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda.
J Pharm Policy Pract. 2019 Dec 3;12:36. doi: 10.1186/s40545-019-0196-8. eCollection 2019.
2
Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities.
J Pharm Policy Pract. 2018 Jul 5;11:15. doi: 10.1186/s40545-018-0142-1. eCollection 2018.
3
Article 4: Impact assessment of supervision performance assessment and recognition strategy (SPARS) to improve supply chain management in health facilities in Uganda: a national pre and post study.
J Pharm Policy Pract. 2021 Feb 4;14(1):14. doi: 10.1186/s40545-020-00290-8.
4
Article 1: Supervision, Performance Assessment, and Recognition Strategy (SPARS) - a multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline.
J Pharm Policy Pract. 2016 May 31;9:21. doi: 10.1186/s40545-016-0070-x. eCollection 2016.
5
Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities.
J Pharm Policy Pract. 2020 Sep 1;13:48. doi: 10.1186/s40545-020-00248-w. eCollection 2020.
6
First regulatory inspections measuring adherence to Good Pharmacy Practices in the public sector in Uganda: a cross-sectional comparison of performance between supervised and unsupervised facilities.
J Pharm Policy Pract. 2016 May 4;9:18. doi: 10.1186/s40545-016-0068-4. eCollection 2016.
7
Competency in supportive supervision: a study of public sector medicines management supervisors in Uganda.
J Pharm Policy Pract. 2017 Oct 11;10:33. doi: 10.1186/s40545-017-0121-y. eCollection 2017.
8
'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda.
J Pharm Policy Pract. 2016 Jun 7;9:22. doi: 10.1186/s40545-016-0071-9. eCollection 2016.
9
Supportive supervision and constructive relationships with healthcare workers support CHW performance: Use of a qualitative framework to evaluate CHW programming in Uganda.
Hum Resour Health. 2018 Feb 13;16(1):11. doi: 10.1186/s12960-018-0272-1.
10
Assessing the quality of the supervision of reproductive health services in Uganda.
QA Brief. 1998 Jun;7(1):11-5.
引用本文的文献
1
Evaluation of Rational Drug Use Based on WHO/INRUD Core Drug Use Indicators in a Secondary Care Hospital: A Cross-Sectional Study in Western Uganda.
Drug Healthc Patient Saf. 2023 Sep 14;15:125-135. doi: 10.2147/DHPS.S424050. eCollection 2023.
2
Compliance of public health facilities with essential medicines and health supplies redistribution guidelines in Mbale district, Eastern Uganda: a mixed-methods study.
J Pharm Policy Pract. 2023 Feb 28;16(1):32. doi: 10.1186/s40545-023-00545-0.
本文引用的文献
1
Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy.
J Pharm Policy Pract. 2018 Oct 15;11:23. doi: 10.1186/s40545-018-0150-1. eCollection 2018.
2
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
Value Health. 2018 Jul;21(7):759-761. doi: 10.1016/j.jval.2017.12.016. Epub 2018 Feb 21.
3
Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities.
J Pharm Policy Pract. 2018 Jul 5;11:15. doi: 10.1186/s40545-018-0142-1. eCollection 2018.
4
Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries.
BMJ Glob Health. 2017 Apr 13;2(2):e000243. doi: 10.1136/bmjgh-2016-000243. eCollection 2017.
5
Supply chain management of health commodities for reducing global disease burden.
Res Social Adm Pharm. 2017 Jul-Aug;13(4):871-874. doi: 10.1016/j.sapharm.2016.08.008. Epub 2016 Sep 12.
6
Article 1: Supervision, Performance Assessment, and Recognition Strategy (SPARS) - a multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline.
J Pharm Policy Pract. 2016 May 31;9:21. doi: 10.1186/s40545-016-0070-x. eCollection 2016.
7
First regulatory inspections measuring adherence to Good Pharmacy Practices in the public sector in Uganda: a cross-sectional comparison of performance between supervised and unsupervised facilities.
J Pharm Policy Pract. 2016 May 4;9:18. doi: 10.1186/s40545-016-0068-4. eCollection 2016.
8
Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening.
Global Health. 2011 Aug 1;7:25. doi: 10.1186/1744-8603-7-25.
9
Cost and effectiveness analysis of immunization service delivery support in Andhra Pradesh, India.
Bull World Health Organ. 2008 Mar;86(3):221-8. doi: 10.2471/blt.06.039495.
Zotero 插件